Thus, the classification of many tumours remains ambiguous, e.g. of MSI tumours without MLH1 promoter methylation but with severe mutational profiles and earlier onset of the disease compared to Lynch associated tumours, as reported here and elsewhere [31], [32]. The gene discussed is MLH1; the disease is neoplasm.